查找临床试验

已按「子宫内膜癌」检索,对应国际通用词 endometrial cancer

试验不在中国怎么办?

共找到 12 项正在招募的试验(在欧美日韩等发达国家设有中心)

数据更新于 10:03,每 5 分钟自动同步
正在招募I 期 / II 期NCT07109726

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

United States、Puerto Rico

年龄 18 Years不限

Terremoto Biosciences Inc.

正在招募不适用NCT07741968

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

United States

年龄 18 Years不限

City of Hope Medical Center

正在招募不适用NCT05655260

PErsonalized TReatment for Endometrial Carcinoma

Finland

年龄 18 Years100 Years

University of Helsinki

正在招募不适用NCT07397624

Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer

Italy

年龄 21 Years75 Years

Centro di Riferimento Oncologico - Aviano

正在招募I 期 / II 期NCT04657068

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

United States、France、Spain、United Kingdom

年龄 18 Years不限

Artios Pharma Ltd

正在招募不适用NCT05349227

Comprehensive Outcomes for After Cancer Health

United States

年龄 18 Years不限

Pack Health

正在招募不适用NCT07406087

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

United States

年龄 21 Years45 Years

Kaiser Permanente

正在招募不适用NCT07062016

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

United States

年龄 18 Years不限

Mayo Clinic

正在招募II 期中国有中心NCT06760819

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

United States、Australia、Canada、China、Denmark 等 11 国

年龄 18 Years不限

Bayer

正在招募不适用NCT06038032

ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial

Canada

年龄 18 Years不限

University of Alberta

正在招募I 期NCT06218914

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

United States

年龄 18 Years不限

AstraZeneca

正在招募I 期NCT07318324

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

United States

年龄 18 Years不限

M.D. Anderson Cancer Center